Over the last 33 years, acting on modifiable risk factors has helped to prevent deaths caused by ischemic heart disease, new ...

Background Clinical benefit of percutaneous coronary intervention (PCI) in chronic coronary syndromes (CCS) remains ...

VahatiCor CEO Harry Rowland explains how the nitinol A-Flux reducer implant is designed to treat coronary microvascular ...

A growing body of research links several widespread viral infections to sharp, short-term spikes in heart attack and stroke ...

Researchers at University College London have identified a specific mechanism by which GLP-1 receptor agonists, the drug ...

Should all adults with diabetes, including those who are asymptomatic, be screened for peripheral vascular disease (PAD)? According to Shihchen Kuo, RPh, PhD, associate research scientist of internal ...

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a ...

A new study found that chronic wasting disease can sometimes spread silently, with infectious prions present even in animals that show no symptoms. While there is no confirmed human risk, researchers ...

Inflammation is a natural bodily process. It’s a defense system tool used by the body to fight off infections and heal injuries. Think of a time when you’ve cut a finger, for example, or scraped an ...

In randomized trials, finerenone, a nonsteroidal mineralocorticoid receptor antagonist, improved kidney and cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease (CKD).

Total neoadjuvant chemotherapy with FLOT for resectable gastric and gastroesophageal junction adenocarcinoma: Real-world outcomes from a Chilean oncology institution. This is an ASCO Meeting Abstract ...